- Hearing postponed to 24 November 2025 for Global Bioenergies' takeover review.
- New deadline for submitting offers is 12 November 2025.
- Receivership procedure initiated on 29 September 2025.
- Judicial liquidation may lead to delisting with shares likely having zero residual value.
Hearing Postponement
The Commercial Court of Evry has postponed the review of takeover offers for Global Bioenergies to 24 November 2025. This decision follows a hearing held on 3 November 2025.
Offer Submission Deadline
The new deadline for submitting takeover offers is set for 12 November 2025. This extension provides potential buyers additional time to prepare their proposals.
Receivership and Sale Process
Global Bioenergies initiated a pre-pack sale process on 3 June 2025, and the Evry Commercial Court opened a receivership procedure on 29 September 2025 to facilitate a sale plan.
Potential Outcomes
If certain assets or activities are acquired, or if no final offer is made, judicial liquidation proceedings will commence. This could result in the delisting of Global Bioenergies' shares, with their residual value likely being zero due to liabilities exceeding asset sale proceeds.
Financial Statement Delays
The company is unable to finalize its half-year financial statements due to the uncertainty surrounding the ongoing takeover process.
